Literature DB >> 12722925

Neuropathological study of C57BL/6Akita mouse, type 2 diabetic model: enhanced expression of alphaB-crystallin in oligodendrocytes.

Masamitsu Yaguchi1, Kazuaki Nagashima, Tetsuro Izumi, Koichi Okamoto.   

Abstract

The structure of the central and peripheral nervous systems was studied. in the C57BL/6Akita (Akita) mouse, a non-obese type 2 diabetes model characterized by early onset, autosomal dominant inheritance and a mutation of the insulin 2 gene. Usual neuropathological examinations showed no remarkable abnormalities in the brain, spinal cord or sciatic nerve of Akita mice up to 48 weeks of age. However, immunohistochemical examination revealed that expression of alphaB-crystallin was enhanced in oligodendrocytes in the cerebral white matter, especially in the corpus callosum, after 32 weeks of age. The oligodendrocytes were not positive for ubiquitin and HSP25. It is suggested that long-standing hyperglycemia might stress the CNS and thus enhance the expression of alphaB-crystallin in oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722925     DOI: 10.1046/j.1440-1789.2003.00475.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  9 in total

Review 1.  Zeta-crystallin: a moonlighting player in cancer.

Authors:  Matteo Lulli; Daniele Nencioni; Laura Papucci; Nicola Schiavone
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

Review 2.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 3.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

4.  Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.

Authors:  Anne-Sophie de Preux Charles; Valérie Verdier; Jennifer Zenker; Bastian Peter; Jean-Jacques Médard; Thierry Kuntzer; Jacques S Beckmann; Sven Bergmann; Roman Chrast
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 5.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

6.  Genetic and Pharmacologic Models for Type 1 Diabetes.

Authors:  Edward H Leiter; Andrew Schile
Journal:  Curr Protoc Mouse Biol       Date:  2013-03-01

7.  Diabetic Stroke Severity: Epigenetic Remodeling and Neuronal, Glial, and Vascular Dysfunction.

Authors:  Anuradha Kalani; Pradip Kumar Kamat; Neetu Tyagi
Journal:  Diabetes       Date:  2015-10-15       Impact factor: 9.461

8.  Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis.

Authors:  Haruko Nakano; Itsunari Minami; Daniel Braas; Herman Pappoe; Xiuju Wu; Addelynn Sagadevan; Laurent Vergnes; Kai Fu; Marco Morselli; Christopher Dunham; Xueqin Ding; Adam Z Stieg; James K Gimzewski; Matteo Pellegrini; Peter M Clark; Karen Reue; Aldons J Lusis; Bernard Ribalet; Siavash K Kurdistani; Heather Christofk; Norio Nakatsuji; Atsushi Nakano
Journal:  Elife       Date:  2017-12-12       Impact factor: 8.140

9.  Activated ClC-2 Inhibits p-Akt to Repress Myelination in GDM Newborn Rats.

Authors:  Feixiang He; Yuchen Peng; Zhi Yang; Zilu Ge; Yanping Tian; Teng Ma; Hongli Li
Journal:  Int J Biol Sci       Date:  2017-01-15       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.